tradingkey.logo
tradingkey.logo
Search

Dr Reddy's Laboratories Ltd

RDY
Add to Watchlist
15.380USD
0.0000.00%
Close 06/26, 16:00ETQuotes delayed by 15 min
12.81BMarket Cap
26.39P/E TTM

Dr Reddy's Laboratories Ltd

15.380
0.0000.00%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

+15.73%

1 Month

+13.25%

6 Months

+8.62%

Year to Date

+9.54%

1 Year

+2.06%

Key Figures
--Open
0.000High
0.00Volume
26.39P/E TTM
27.35P/E Dynamic
0.091Dividend TTM
0.44%Turnover Ratio
15.380Prev. Close
0.000Low
0.00Turnover
19.14P/E Static
3.17P/B
0.59%Div Yield TTM
8.03%ROA
16.17052wk High
1.02Volume Ratio
668.95MNet Profit
832.69MShares
0.5828EPS TTM
0.27Beta
12.23%ROE
12.18552wk Low
2.46%Amplitude
44.82%Gross Margin
12.81BMarket Cap
12.46Reward/Risk
1.03%Risk Rate

Key Insights

Dr Reddy's Laboratories Ltd's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 49 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 15.12.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Dr Reddy's Laboratories Ltd's Score

Industry at a Glance

Industry Ranking
49 / 157
Overall Ranking
116 / 4566
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Dr Reddy's Laboratories Ltd Highlights

StrengthsRisks
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 11.81%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 11.81%.
Overvalued
The company’s latest PE is 26.39, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 117.02M shares, decreasing 7.30% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 7.88M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.36.

Analyst Rating

Based on 4 analysts
Hold
Current Rating
15.120
Target Price
-0.85%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Dr Reddy's Laboratories Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Dr Reddy's Laboratories Ltd Info

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Ticker SymbolRDY
CompanyDr Reddy's Laboratories Ltd
CEOAghanian (Patrick)
Websitehttps://www.drreddys.com/

FAQs

What is the current price of Dr Reddy's Laboratories Ltd (RDY)?

The current price of Dr Reddy's Laboratories Ltd (RDY) is 15.38.

What is the symbol of Dr Reddy's Laboratories Ltd?

The ticker symbol of Dr Reddy's Laboratories Ltd is RDY.

What is the 52-week high of Dr Reddy's Laboratories Ltd?

The 52-week high of Dr Reddy's Laboratories Ltd is 16.17.

What is the 52-week low of Dr Reddy's Laboratories Ltd?

The 52-week low of Dr Reddy's Laboratories Ltd is 12.19.

What is the market capitalization of Dr Reddy's Laboratories Ltd?

The market capitalization of Dr Reddy's Laboratories Ltd is 12.81B.

Is Dr Reddy's Laboratories Ltd (RDY) currently rated as Buy, Hold, or Sell?

According to analysts, Dr Reddy's Laboratories Ltd (RDY) has an overall rating of signal_hold, with a price target of 15.12.

What is the Earnings Per Share (EPS TTM) of Dr Reddy's Laboratories Ltd (RDY)?

The Earnings Per Share (EPS TTM) of Dr Reddy's Laboratories Ltd (RDY) is 0.58.
KeyAI